IGF2 and rhabdomyosarcoma: Interestingly, mice vaccinated with human IGF2 DNA, producing antibodies cross-reacting with mouse IGF2, were partially protected from a subsequent injection of RMSp53Neu-5 rhabdomyosarcoma cells, showing a significant 60% decrease in the number of lung metastases when compared to untreated controls [186].